Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Jun:182:106380.
doi: 10.1016/j.rmed.2021.106380. Epub 2021 Mar 29.

Disputes over the production and dissemination of misinformation in the time of COVID-19

Mario Cazzola  1 , Vito de Novellis  2 , Andrea Bianco  3 , Paola Rogliani  4 , Maria Gabriella Matera  2
Affiliations
Editorial

Disputes over the production and dissemination of misinformation in the time of COVID-19

Mario Cazzola et al. Respir Med. 2021 Jun.

Abstract

Ultimate coronavirus disease 2019 (COVID-19) mitigation and crisis resolution is dependent on trustworthy data and actionable information. At present time, there is still no cure for COVID-19, although some treatments are being used in severe illness. Regrettably, as the SARS-CoV-2 virus spreads, the lack of cure has been accompanied by an increasing amount of medical misinformation. In particular, there is a lot of misinformation about how to treat patients who have tested positive for SARS-CoV-2 and who are asymptomatic or have mild symptoms and for whom management at home is deemed appropriate. In this editorial, we highlight the risks deriving from this misinformation, which often arises from the publication of studies that are not conceptually and methodologically accurate.

Keywords: Azithromycin; Covid-19; Heparin; Home therapy; Oral corticosteroids.

PubMed Disclaimer

Comment on

Similar articles

See all similar articles

Cited by

References

    1. Tonne C. Lessons from the COVID-19 pandemic for accelerating sustainable development. Environ. Res. 2021;193:110482. - PMC - PubMed
    1. Weiner D.L., Balasubramaniam V., Shah S.I., Javier J.R. COVID-19 impact on research, lessons learned from COVID-19 research, implications for pediatric research. Pediatr. Res. 2020;88(2):148–150. - PubMed
    1. Naeem S.B., Bhatti R. The Covid-19 'infodemic': a new front for information professionals. Health Inf. Libr. J. 2020;37(3):233–239. - PMC - PubMed
    1. Lai C.C., Shih T.P., Ko W.C., Tang H.J., Hsueh P.R. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int. J. Antimicrob. Agents. 2020;55(3):105924. - PMC - PubMed
    1. Pirro M. Covid, svolta con la terapia napoletana: «Medicinali subito e nessun decesso». Available at: https://www.ilmattino.it/primopiano/sanita/coronavirus_terapia_napoletan.....